Converge to Host Second Quarter Fiscal 2024 Conference Call
Get Alerts CTS Hot Sheet
Join SI Premium – FREE
Conference Call Details:
Date:
Time:
Participant Webcast Link:
Webcast Link – https://app.webinar.net/JRKZ82MjxEQ
Participant Dial-in Details with Operator Assistance:
Conference ID: 50386
North American Toll Free: 1-800-836-8184
International Toll-Free Numbers:
You may register and enter your phone number to receive an instant automated call back via https://emportal.ink/3VPeZPg
Recording Playback:
Webcast Link - https://app.webinar.net/JRKZ82MjxEQ
North American Toll Free: 1-888-660-6345
Replay Code: 50386 #
Expiry Date:
Please connect at least 15 minutes prior to the conference call to ensure time for any software download that may be required to access the webcast. A live audio webcast accompanied by presentation slides and archive of the conference call and webcast will be available by visiting the Company's website at https://convergetp.com/investor-relations/.
About Converge
Converge Technology Solutions Corp. is a services-led, software-enabled, IT & Cloud Solutions provider focused on delivering industry-leading solutions. Converge's global approach delivers advanced analytics, artificial intelligence (AI), application modernization, cloud platforms, cybersecurity, digital infrastructure, and digital workplace offerings to clients across various industries. The Company supports these solutions with advisory, implementation, and managed services expertise across all major IT vendors in the marketplace. This multi-faceted approach enables Converge to address the unique business and technology requirements for all clients in the public and private sectors. For more information, visit convergetp.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/converge-to-host-second-quarter-fiscal-2024-conference-call-302200425.html
SOURCE Converge Technology Solutions Corp.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wolfe Research starts Ferrari at Outperform, sees 'solid upside potential'
- Vanda Pharmaceuticals Announces FDA Rare Pediatric Disease Designation for Investigational Therapy for Charcot-Marie-Tooth Disease Type 2S
- Equifax Announces Earnings Release Date and Conference Call for Second Quarter 2026 Results
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share